Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Assets (2018 - 2025)

Dna X (SONM) has disclosed Assets for 8 consecutive years, with $40.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets fell 18.17% year-over-year to $40.2 million, compared with a TTM value of $40.2 million through Sep 2025, down 18.17%, and an annual FY2024 reading of $39.7 million, down 29.09% over the prior year.
  • Assets was $40.2 million for Q3 2025 at Dna X, up from $36.1 million in the prior quarter.
  • Across five years, Assets topped out at $58.6 million in Q3 2023 and bottomed at $36.0 million in Q1 2025.
  • Average Assets over 5 years is $44.6 million, with a median of $41.1 million recorded in 2021.
  • The sharpest move saw Assets crashed 42.8% in 2021, then soared 44.11% in 2023.
  • Year by year, Assets stood at $41.1 million in 2021, then soared by 30.65% to $53.7 million in 2022, then increased by 4.39% to $56.0 million in 2023, then decreased by 29.09% to $39.7 million in 2024, then rose by 1.21% to $40.2 million in 2025.
  • Business Quant data shows Assets for SONM at $40.2 million in Q3 2025, $36.1 million in Q2 2025, and $36.0 million in Q1 2025.